BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10672334)

  • 1. Neuropeptides of the cholecystokinin group: effects and mechanisms of action on the gastro-intestinal and gall bladder motility.
    Milenov K; Kalfin R; Todorov S; Raichev P
    Acta Physiol Pharmacol Bulg; 1998; 23(3-4):85-91. PubMed ID: 10672334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cholecystokinine on the gallbladder motility: interaction with somatostatin and vasoactive intestinal peptide.
    Milenov K; Rakovska A; Kalfin R
    Acta Physiol Pharmacol Bulg; 1995; 21(3):67-76. PubMed ID: 8868369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin inhibits cholecystokinin-induced contraction of isolated gallbladder smooth muscle cells.
    Yamasaki T; Chijiiwa K; Chijiiwa Y
    J Surg Res; 1995 Dec; 59(6):743-6. PubMed ID: 8538175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic mechanism in cholecystokinin action on gall bladder motility.
    Milenov K; Rakovska A; Kalfin R
    Methods Find Exp Clin Pharmacol; 1988 Dec; 10(12):741-6. PubMed ID: 3236942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovine model for clear-cut study on the role of cholecystokinin in antral, small intestinal and gallbladder motility.
    Romański KW
    Pol J Pharmacol; 2004; 56(2):247-56. PubMed ID: 15156076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of desamino-cholecystokinin-octapeptide (CCK-7) on the intraluminal pressure and myoelectrical activity of the gall-bladder, stomach, and small intestine in conscious dogs.
    Milenov E; Nieber K; Niedrich H; Oehme P; Vogt WE
    Br J Pharmacol; 1983 Dec; 80(4):681-9. PubMed ID: 6100845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin (pancreozymin). Synthesis and properties of the N alpha-acetyl-derivative of cholecystokinin 27-33.
    Bodanszky M; Tolle JC; Gardner JD; Walker MD; Mutt V
    Int J Pept Protein Res; 1980 Nov; 16(5):402-11. PubMed ID: 6163740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that acetylcholine released by gastrin and related polypeptides contributes to their effect on gastrointestinal motility.
    Vizi SE; Bertaccini G; Impicciatore M; Knoll J
    Gastroenterology; 1973 Feb; 64(2):268-77. PubMed ID: 4686335
    [No Abstract]   [Full Text] [Related]  

  • 9. Mode of action of cholecystokinin and related peptides on gallbladder muscle.
    Yau WM; Makhlouf GM; Edwards LE; Farrar JT
    Gastroenterology; 1973 Sep; 65(3):451-6. PubMed ID: 4728980
    [No Abstract]   [Full Text] [Related]  

  • 10. Intraduodenal fat and amino acids activate gallbladder motility in the rainbow trout, Oncorhynchus mykiss.
    Aldman G; Holmgren S
    Gen Comp Endocrinol; 1995 Oct; 100(1):27-32. PubMed ID: 8575655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin increases small intestinal response to cholecystokinin in leptin-deficient obese mice.
    Kiely JM; Graewin SJ; Pitt HA; Swartz-Basile DA
    J Surg Res; 2005 Mar; 124(1):146-50. PubMed ID: 15734493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin antagonists: pharmacological and therapeutic potential.
    Herranz R
    Med Res Rev; 2003 Sep; 23(5):559-605. PubMed ID: 12789687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mu-Opiate receptor agonist loperamide blocks bethanechol-induced gallbladder contraction, despite higher cholecystokinin plasma levels in man.
    Otto B; Mawe GM; Riepl RL
    Neurogastroenterol Motil; 2005 Oct; 17(5):761-6. PubMed ID: 16185316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CCK in gallbladder function.
    Schjoldager BT
    Ann N Y Acad Sci; 1994 Mar; 713():207-18. PubMed ID: 8185161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the tissue-specific processing of procholecystokinin in the brain and gut--a short review.
    Rehfeld JF; Bungaard JR; Friis-Hansen L; Goetze JP
    J Physiol Pharmacol; 2003 Dec; 54 Suppl 4():73-9. PubMed ID: 15075450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The specificity of cholecystokinin action on the gall-bladder.
    Greenwell JR; Harper AA; Lake HJ; Sahay JN
    J Physiol; 1973 Feb; 229(1):19P-20P. PubMed ID: 4689966
    [No Abstract]   [Full Text] [Related]  

  • 17. Gastrin and cholecystokinin of the bullfrog, Rana catesbeiana, have distinct effects on gallbladder motility and gastric acid secretion in vitro.
    Nielsen KG; Bomgren P; Holmgren S; Johnsen AH
    Gen Comp Endocrinol; 1998 Nov; 112(2):247-54. PubMed ID: 9784308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotensin and cholecystokinin depress motility in isolated Lumbricus terrestris crop-gizzard preparations.
    Gibbs S; DeGolier TF
    Comp Biochem Physiol A Mol Integr Physiol; 2008 Dec; 151(4):682-6. PubMed ID: 18790067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor interaction between cimetidine and cholecystokinin-related peptides in the gall bladder.
    Stasiewicz J; Szałaj W; Gabryelewicz A
    Pol J Pharmacol Pharm; 1980; 32(5):643-6. PubMed ID: 7267456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin constricts the canine cystic duct.
    Courtney DF; Clanachan AS; Scott GW
    Gastroenterology; 1983 Nov; 85(5):1154-9. PubMed ID: 6311657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.